Explore more publications!
Connecticut Health Digest
Submit Press Release

Connecticut Health Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Connecticut Health Digest.

September 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

Press releases published on August 18, 2025

Sienna Announces Offering of $175 Million of 4.112% Series E Senior Unsecured Debentures and Closing of Previously Announced Acquisition in Greater Toronto Area
August 18, 2025

Sienna Announces Offering of $175 Million of 4.112% Series E Senior Unsecured Debentures and Closing of Previously Announced Acquisition in Greater Toronto Area

Indeterminate GlobeNewswire
Opthea Provides Corporate Update
August 18, 2025

Opthea Provides Corporate Update

Indeterminate GlobeNewswire
Tevogen CEO Donates Personal Shares to Support Local Law Enforcement
August 18, 2025

Tevogen CEO Donates Personal Shares to Support Local Law Enforcement

Indeterminate GlobeNewswire
Tevogen CEO Donates Personal Shares to Support Brain Injury Recovery
August 18, 2025

Tevogen CEO Donates Personal Shares to Support Brain Injury Recovery

Indeterminate GlobeNewswire
Vor Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 18, 2025

Vor Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
Invivyd Announces Continued Neutralizing Activity of PEMGARDA® (pemivibart) and VYD2311 Against Currently Dominant SARS-CoV-2 Variant XFG (“Stratus”)
August 18, 2025

Invivyd Announces Continued Neutralizing Activity of PEMGARDA® (pemivibart) and VYD2311 Against Currently Dominant SARS-CoV-2 Variant XFG (“Stratus”)

Indeterminate GlobeNewswire
Eagle Pharmaceuticals Announces 2025 Annual Meeting Date
August 18, 2025

Eagle Pharmaceuticals Announces 2025 Annual Meeting Date

Indeterminate GlobeNewswire
Resmed Announces Election of Nicole Mowad-Nassar to Board of Directors and Upcoming Retirement of Rich Sulpizio
August 18, 2025

Resmed Announces Election of Nicole Mowad-Nassar to Board of Directors and Upcoming Retirement of Rich Sulpizio

Indeterminate GlobeNewswire
Precision Optics to Participate in the Lytham Partners 2025 Consumer & Technology Investor Summit on August 19, 2025
August 18, 2025

Precision Optics to Participate in the Lytham Partners 2025 Consumer & Technology Investor Summit on August 19, 2025

Indeterminate GlobeNewswire
Iovance’s Amtagvi® (lifileucel) Receives Health Canada Approval for Advanced Melanoma
August 18, 2025

Iovance’s Amtagvi® (lifileucel) Receives Health Canada Approval for Advanced Melanoma

Indeterminate GlobeNewswire
Nyxoah Reports Second Quarter Financial and Operating Results
August 18, 2025

Nyxoah Reports Second Quarter Financial and Operating Results

Indeterminate GlobeNewswire
Nyxoah Présente ses Résultats Financiers et d’Exploitation pour le Second Trimestre 2025
August 18, 2025

Nyxoah Présente ses Résultats Financiers et d’Exploitation pour le Second Trimestre 2025

Indeterminate GlobeNewswire
Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
August 18, 2025

Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
ORIC® Pharmaceuticals Expands Leadership Team with the Appointment of Kevin Brodbeck as Chief Technical Officer
August 18, 2025

ORIC® Pharmaceuticals Expands Leadership Team with the Appointment of Kevin Brodbeck as Chief Technical Officer

Indeterminate GlobeNewswire
Scientific Industries to Host Second Quarter Fiscal Year 2025 Financial Results Investor Call on August 20, 2025
August 18, 2025

Scientific Industries to Host Second Quarter Fiscal Year 2025 Financial Results Investor Call on August 20, 2025

Indeterminate GlobeNewswire
EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
August 18, 2025

EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Indeterminate GlobeNewswire
The Association of American Physicians and Surgeons Filed an Amicus Brief in the Ninth Circuit in Support of Restoring California’s Religious Exemption to Vaccination
August 18, 2025

The Association of American Physicians and Surgeons Filed an Amicus Brief in the Ninth Circuit in Support of Restoring California’s Religious Exemption to Vaccination

Indeterminate GlobeNewswire
HCW Biologics Reports Second Quarter 2025 Business Highlights and Financial Results
August 18, 2025

HCW Biologics Reports Second Quarter 2025 Business Highlights and Financial Results

Indeterminate GlobeNewswire
Mesa Laboratories Executes Previously-Announced Strategic Financing Plan
August 18, 2025

Mesa Laboratories Executes Previously-Announced Strategic Financing Plan

Indeterminate GlobeNewswire
BioNTX Announces 2025 Tech Transfer Showcase Finalists Pitch Competition at the 2025 iC³® Life Science & Healthcare Innovation Summit
August 18, 2025

BioNTX Announces 2025 Tech Transfer Showcase Finalists Pitch Competition at the 2025 iC³® Life Science & Healthcare Innovation Summit

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions